SH2D3C and viral infectious disease: NSP3, 12, and 13 are also under investigation as drug targets for COVID-19 (49–52), whereas Spike protein is known to mediate host cell entry (53) and ORF3a protein is described as modulating the host immune response to virus infection, hence having a role in pathogenesis (54, 55).